Abstract:Double strand breaks (DSBs) at specific loci can be efficiently induced by genome editing tools. It is believed that most DSBs are repaired by either non-homologous end joining (NHEJ) or homology directed repair (HDR) using synthetic DNA templates. Our study aims to evaluate if DNA DSBs in human preimplantation embryos also repaired by an alternative mechanism known as gene conversion (GC). Pre-tested sgRNAs and Cas9 protein were co-injected into human MII oocytes or zygotes to target heterozygous MYH7 (g.15819 C>T; NG_007884.1) and homozygous wild-type (WT) MYBPC3 (g.9836, NC_000011.10) loci. Injected embryos were cultured for 3 days and then individual blastomeres of cleaving embryos were isolated and analyzed by sequencing at a single-cell level. DNA from each individual blastomere was amplified and the target region was sequenced by Sanger. Since gene conversion results in loss of heterozygosity (LOH) around target region, we evaluated the presence or loss of single-nucleotide polymorphisms (SNPs) adjacent to the target region. As expected, most DSBs at the heterozygous MYH7 locus were repaired by NHEJ (58.3%; 70/120) resulting in additional indel mutations on the mutant allele. However, remaining 41.7% (50/120) of blastomeres lost the mutant allele and were presented by the WT allele. We excluded possibility of deletions in these samples abut showed LOH at adjacent loci. When targeting both alleles at homozygous MYBPC3 locus, we found that 40.2% (129/321) blastomeres appeared with identical indel mutations on both parental alleles, indicating that GC and NHEJ compete and interplay with each other within the same cell. In contrast, frequency of HDR via exogenous synthetic DNA templates is limited. We report here that in addition to NHEJ and HDR, human embryos frequently employ an alternative repair mechanism known as gene conversion where intact endogenous homologous sequences are used as templates. While gene conversion could be applicable for gene correction, extensive LOH presents a safety concern.

CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein

Development and application of CRISPR/Cas9 technologies in genomic editing.

Correction of a pathogenic gene mutation in human embryos

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos

GENE CONVERSION IN HUMAN EMBRYOS INDUCED BY GENE EDITING.

Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells

A non-inheritable maternal Cas9-based multiple-gene editing system in mice

Highly Efficient Ssodn‐mediated Homology‐directed Repair of DSBs Generated by CRISPR/Cas9 in Human 3PN Zygotes

Production of gene-edited pigs harboring orthologous human mutations via double cutting by CRISPR/Cas9 with long single-stranded DNAs as homology-directed repair templates by zygote injection

Precise Gene Deletion and Replacement Using the CRISPR/Cas9 System in Human Cells

Genome editing of porcine zygotes via lipofection of two guide RNAs using a CRISPR/Cas9 system

Efficient Inversions and Duplications of Mammalian Regulatory DNA Elements and Gene Clusters by CRISPR/Cas9

An oocyte‐specific Cas9‐expressing mouse for germline CRISPR/Cas9‐mediated genome editing

Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes

CRISPR/Cas9 technology: applications in oocytes and early embryos

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

Generation of an Oocyte-Specific Cas9 Transgenic Mouse for Genome Editing.

CRISPR/Cas9-mediated Targeted Chromosome Elimination.

A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells

Using CRISPR-Cas9 for Therapeutic Protein Production (Review Article)